首页> 美国卫生研究院文献>PLoS Clinical Trials >Towards PDT with Genetically Encoded Photosensitizer KillerRed: A Comparison of Continuous and Pulsed Laser Regimens in an Animal Tumor Model
【2h】

Towards PDT with Genetically Encoded Photosensitizer KillerRed: A Comparison of Continuous and Pulsed Laser Regimens in an Animal Tumor Model

机译:用遗传编码的光敏剂KillerRed走向PDT:在动物肿瘤模型中连续和脉冲激光治疗方案的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The strong phototoxicity of the red fluorescent protein KillerRed allows it to be considered as a potential genetically encoded photosensitizer for the photodynamic therapy (PDT) of cancer. The advantages of KillerRed over chemical photosensitizers are its expression in tumor cells transduced with the appropriate gene and direct killing of cells through precise damage to any desired cell compartment. The ability of KillerRed to affect cell division and to induce cell death has already been demonstrated in cancer cell lines in vitro and HeLa tumor xenografts in vivo. However, the further development of this approach for PDT requires optimization of the method of treatment. In this study we tested the continuous wave (593 nm) and pulsed laser (584 nm, 10 Hz, 18 ns) modes to achieve an antitumor effect. The research was implemented on CT26 subcutaneous mouse tumors expressing KillerRed in fusion with histone H2B. The results showed that the pulsed mode provided a higher rate of photobleaching of KillerRed without any temperature increase on the tumor surface. PDT with the continuous wave laser was ineffective against CT26 tumors in mice, whereas the pulsed laser induced pronounced histopathological changes and inhibition of tumor growth. Therefore, we selected an effective regimen for PDT when using the genetically encoded photosensitizer KillerRed and pulsed laser irradiation.
机译:红色荧光蛋白KillerRed具有很强的光毒性,因此可以将其视为潜在的遗传编码的光敏剂,用于癌症的光动力疗法(PDT)。相较于化学光敏剂,KillerRed的优势在于其在通过适当基因转导的肿瘤细胞中表达,并通过精确破坏任何所需的细胞区室而直接杀死细胞。 KillerRed影响细胞分裂和诱导细胞死亡的能力已经在体外癌细胞系和体内HeLa肿瘤异种移植物中得到证实。但是,PDT这种方法的进一步发展需要优化治疗方法。在这项研究中,我们测试了连续波(593 nm)和脉冲激光(584 nm,10 Hz,18 ns)模式,以达到抗肿瘤作用。该研究是针对表达KillerRed与组蛋白H2B融合的CT26皮下小鼠肿瘤进行的。结果表明,脉冲模式提供了更高的KillerRed光漂白率,而肿瘤表面没有任何温度升高。用连续波激光治疗PDT对小鼠的CT26肿瘤无效,而脉冲激光则引起明显的组织病理学改变和对肿瘤生长的抑制作用。因此,当使用遗传编码的光敏剂KillerRed和脉冲激光辐照时,我们选择了一种有效的PDT治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号